179 related articles for article (PubMed ID: 30504643)
1. Kluyvera ascorbata as a Pathogen in Adults and Children: Clinical Features and Antibiotic Susceptibilities in a Single Center Study.
Lee J; Hwang JH; Jo DS; Lee HS; Hwang JH
Jpn J Infect Dis; 2019 May; 72(3):142-148. PubMed ID: 30504643
[TBL] [Abstract][Full Text] [Related]
2. Urinary tract infection caused by Kluyvera ascorbata in a child: case report and review of the kluyvera infections in children.
Ruffini E; Pace F; Carlucci M; De Conciliis E; Staffolani P; Carlucci A
Minerva Pediatr; 2008 Dec; 60(6):1451-4. PubMed ID: 18971906
[TBL] [Abstract][Full Text] [Related]
3. A case of urinary tract infection caused by Kluyvera ascorbata in an infant: case report and review of the literature.
Isozaki A; Shirai K; Mimura S; Takahashi M; Furushima W; Kawano Y
J Infect Chemother; 2010 Dec; 16(6):436-8. PubMed ID: 20454915
[TBL] [Abstract][Full Text] [Related]
4. Clinically significant Kluyvera infections: a report of seven cases.
Carter JE; Evans TN
Am J Clin Pathol; 2005 Mar; 123(3):334-8. PubMed ID: 15716228
[TBL] [Abstract][Full Text] [Related]
5. Urinary tract infection caused by Kluyvera ascorbata in an immunocompromised patient: case report and review.
Torre D; Crespi E; Bernasconi M; Rapazzini P
Scand J Infect Dis; 2005; 37(5):375-8. PubMed ID: 16051578
[TBL] [Abstract][Full Text] [Related]
6. [Kluyvera ascorbata bacteremia in an adult patient].
López-Larramona G; Gómez-de-Oña E; Maestre-Muñiz MM; Ruiz-Chicote AM; Galán-Dorado E; González-Delgado L
Rev Esp Quimioter; 2013 Sep; 26(3):226-7. PubMed ID: 24080889
[No Abstract] [Full Text] [Related]
7. Urosepsis caused by Kluyvera Ascorbata in a Pregnant Woman.
Erbin A; Gozdas HT; Guler Y; Canat HL
J Coll Physicians Surg Pak; 2020 Mar; 30(3):324-326. PubMed ID: 32169146
[TBL] [Abstract][Full Text] [Related]
8. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
Pang F; Jia XQ; Zhao QG; Zhang Y
Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
[TBL] [Abstract][Full Text] [Related]
9. Enterobacteriaceae Sepsis Outcome Programme annual report, 2013.
Turnidge JD; Gottlieb T; Mitchell DH; Coombs GW; Daly DA; Bell JM;
Commun Dis Intell Q Rep; 2014 Dec; 38(4):E327-33. PubMed ID: 25631595
[TBL] [Abstract][Full Text] [Related]
10. Natural antimicrobial susceptibility patterns of Kluyvera ascorbata and Kluyvera cryocrescens strains and review of the clinical efficacy of antimicrobial agents used for the treatment of Kluyvera infections.
Stock I
J Chemother; 2005 Apr; 17(2):143-60. PubMed ID: 15920899
[TBL] [Abstract][Full Text] [Related]
11. Clinical and microbiological features of Providencia bacteremia: experience at a tertiary care hospital.
Choi HK; Kim YK; Kim HY; Park JE; Uh Y
Korean J Intern Med; 2015 Mar; 30(2):219-25. PubMed ID: 25750564
[TBL] [Abstract][Full Text] [Related]
12. Kluyvera ascorbata infection in a neonate.
Ochi F; Tauchi H; Mizumoto M; Miyamoto H; Ishii E
Pediatr Int; 2017 May; 59(5):640-641. PubMed ID: 28402087
[No Abstract] [Full Text] [Related]
13. Infection in burn patients in a referral center in Colombia.
Ramirez-Blanco CE; Ramirez-Rivero CE; Diaz-Martinez LA; Sosa-Avila LM
Burns; 2017 May; 43(3):642-653. PubMed ID: 28185802
[TBL] [Abstract][Full Text] [Related]
14. Etiologies of community-onset urinary tract infections requiring hospitalization and antimicrobial susceptibilities of causative microorganisms.
Chiu CC; Lin TC; Wu RX; Yang YS; Hsiao PJ; Lee Y; Lin JC; Chang FY
J Microbiol Immunol Infect; 2017 Dec; 50(6):879-885. PubMed ID: 28087318
[TBL] [Abstract][Full Text] [Related]
15. Device-associated nosocomial infection rates in intensive care units at Cairo University hospitals: first step toward initiating surveillance programs in a resource-limited country.
El-Kholy A; Saied T; Gaber M; Younan MA; Haleim MM; El-Sayed H; El-Karaksy H; Bazara'a H; Talaat M
Am J Infect Control; 2012 Aug; 40(6):e216-20. PubMed ID: 22418610
[TBL] [Abstract][Full Text] [Related]
16. [Community- and non-community-acquired bacteremia: correlation between empiric antimicrobial therapy and susceptibility of micro-organisms isolated during 2007 in the Ile-de-France microbiologists network].
Porcheret H; Barraud D; Bingen M; Rabenja T; Costa Y; Estève V; Faibis F; Demachy MC; Scanvic A; Vallée E; Péan Y
Pathol Biol (Paris); 2010 Apr; 58(2):e7-e14. PubMed ID: 19875246
[TBL] [Abstract][Full Text] [Related]
17. Enterobacter bacteremia: Clinical features, risk factors for multiresistance and mortality in a Chinese University Hospital.
Ye Y; Li JB; Ye DQ; Jiang ZJ
Infection; 2006 Oct; 34(5):252-7. PubMed ID: 17033748
[TBL] [Abstract][Full Text] [Related]
18. Extended-Spectrum beta (β)-Lactamases and Antibiogram in Enterobacteriaceae from Clinical and Drinking Water Sources from Bahir Dar City, Ethiopia.
Abera B; Kibret M; Mulu W
PLoS One; 2016; 11(11):e0166519. PubMed ID: 27846254
[TBL] [Abstract][Full Text] [Related]
19. Serratia bacteremia in a large university hospital: trends in antibiotic resistance during 10 years and implications for antibiotic use.
Choi SH; Kim YS; Chung JW; Kim TH; Choo EJ; Kim MN; Kim BN; Kim NJ; Woo JH; Ryu J
Infect Control Hosp Epidemiol; 2002 Dec; 23(12):740-7. PubMed ID: 12517017
[TBL] [Abstract][Full Text] [Related]
20. Changing pattern of neonatal bacteremia. Microbiology and antibiotic resistance.
Ellabib MS; Ordonez A; Ramali A; Walli A; Benayad T; Shebrlo H
Saudi Med J; 2004 Dec; 25(12):1951-6. PubMed ID: 15711674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
